Multiple Sclerosis

Mallinckrodt MNK14130050  <- click for more information

Basic Eligibility Criteria:

  • Participants 18 years or older
  • Must have been diagnosed with Relapse Remitting Multiple Sclerosis
  • Pateint planning to initiate Acthar Gel for treatment of acute MS exacerbation.

 

Novartis CFTY20D2403 (RRMS) observational <- click for more information

Observational study for patients starting on Fingolimod

Basic Eligibility Criteria:

  • Starting Fingolimod
  • Starting another DMT or started within a maximim of 6 months prior to study entry.
  • EDSS score of 0 to 5.5

Sanofi - OBS13434 - observational

Basic Eligibility Criteria:

  • Diagnosis of a of RMS
  • Initiated Lemtrada treatment for the first time within the last 8 weeks of study entry

ADAMAS - ADS-AMT-MS301 <- click for more information

Basic Eligibility Criteria:

  • Participants 18 to 70 years old
  • Must have been diagnosed with Multiple Sclerosis
  • Stable medications for 30 days prior to screening
  • Sufficient ambulatory ability
  • EDSS - max 6.5 at screening

If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff at 203.333.1151 and we will be happy to answer any of your questions.